Complement activation and cardiovascular disease

被引:26
作者
Bjerre, M. [1 ]
Hansen, T. K.
Flyvbjerg, A.
机构
[1] Aarhus Univ Hosp, Med Res Labs, Inst Clin, DK-8000 Aarhus, Denmark
关键词
complement; inflammation; cardiovascular disease; ischemia; diabetes mellitus;
D O I
10.1055/s-0028-1083786
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mechanisms by which tissue injury after acute myocardial infarction occurs have not been fully elucidated, but considerable evidence Suggests that activation of complement plays an important role in the pathophysiology. Reperfusion of the ischemic myocardium is strictly necessary to rescue the exposed tissue from eventual death. However, reversion of the blood supply is also associated with reperfusion injury contributing to tissue injury. Activation of the complement system has indisputable beneficial effects in the immune defense and in the clearance of damaged tissue and apoptotic cells, but excessive activation of the system may lead to uncontrolled tissue damage. This review focuses on the role of complement activation, with focus on the lectin pathway, endothelial dysfunction and cardiovascular diseases, including ischemic heart disease and diabetic angiopathy. Finally, potential therapeutic strategies targeting the complement system are discussed.
引用
收藏
页码:626 / 634
页数:9
相关论文
共 116 条
  • [1] LIMITATION OF REPERFUSION INJURY BY A MONOCLONAL-ANTIBODY TO C5A DURING MYOCARDIAL-INFARCTION IN PIGS
    AMSTERDAM, EA
    STAHL, GL
    PAN, HL
    RENDIG, SV
    FLETCHER, MP
    LONGHURST, JC
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 268 (01): : H448 - H457
  • [2] Armstrong PW, 2007, JAMA-J AM MED ASSOC, V297, P43
  • [3] Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
    Armstrong, PW
    Adams, PX
    Al-Khalidi, HR
    Hamm, C
    Holmes, D
    O'Neill, W
    Todaro, TG
    Vahanian, A
    Van de Werf, F
    Granger, CB
    [J]. AMERICAN HEART JOURNAL, 2005, 149 (03) : 402 - 407
  • [4] The role of the complement system in ischemia-reperfusion injury
    Arumugam, TV
    Shiels, IA
    Woodruff, TM
    Granger, DN
    Taylor, SM
    [J]. SHOCK, 2004, 21 (05): : 401 - 409
  • [5] Therapeutic inhibition of the complement system. Y2K update
    Asghar, SS
    Pasch, MC
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2000, 5 : E63 - E82A
  • [6] Intestinal ischemia-reperfusion injury is mediated by the membrane attack complex
    Austen, WG
    Kyriakides, C
    Favuzza, J
    Wang, Y
    Kohzik, L
    Moore, FD
    Hechtman, HB
    [J]. SURGERY, 1999, 126 (02) : 343 - 348
  • [7] Rescue therapy with C1-esterase inhibitor concentrate after emergency coronary surgery for failed PTCA
    Bauernschmitt, R
    Bohrer, H
    Hagl, S
    [J]. INTENSIVE CARE MEDICINE, 1998, 24 (06) : 635 - 638
  • [8] Generation of reactive oxygen species by endothelial and smooth muscle cells:: Influence of hyperglycemia and metformin
    Bellin, C.
    de Wiza, D. H.
    Wiernsperger, N. F.
    Roesen, P.
    [J]. HORMONE AND METABOLIC RESEARCH, 2006, 38 (11) : 732 - 739
  • [9] Clusterin and the terminal complement pathway synthesized by human umbilical vein endothelial cells are closely linked when detected on co-cultured agarose beads
    Berge, V
    Johnson, E
    Hogasen, K
    [J]. APMIS, 1997, 105 (01) : 17 - 24
  • [10] Vitronectin modulates the expression of complement components of the terminal pathway synthesized by human umbilical vein endothelial cells in vitro
    Berge, V
    Berge, KE
    Johnson, E
    [J]. APMIS, 1996, 104 (7-8) : 523 - 530